STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CRWV (CRWV) holder files Form 144 to sell 1,000 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder filed a notice of proposed sale of 1,000 shares of common stock, with an aggregate market value of $89,950.00. The shares are to be sold on NASDAQ around 02/09/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services. These shares were originally acquired as founders shares from the issuer on 02/25/2019. The filing also lists extensive Rule 10b5-1-labeled sales of common stock over the past three months by Brannin McBee, related trusts and entities, and a non-affiliate donee, each with specified dates, share amounts, and gross proceeds.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does the CRWV Form 144 filing disclose?

The filing discloses a planned sale of 1,000 common shares with an aggregate market value of $89,950.00. It also itemizes prior three-month common stock sales labeled as 10b5-1 Sales by Brannin McBee, related trusts and entities, and a non-affiliate donee.

How many CRWV shares are planned to be sold and when?

The notice covers a proposed sale of 1,000 shares of common stock. The approximate date of sale is listed as 02/09/2026, with the transaction to occur on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

How were the CRWV shares in this Form 144 originally acquired?

The 1,000 common shares covered by the notice were acquired on 02/25/2019 as “Founders Shares” from the issuer. The filing shows the acquisition date and labels the nature of the acquisition transaction as founders shares, with payment dated the same day.

Which broker and exchange are named for the planned CRWV share sale?

The planned sale identifies Morgan Stanley Smith Barney LLC Executive Financial Services as broker, at 1 New York Plaza, 8th Floor, New York, NY 10004. The shares are expected to be sold on NASDAQ, with an aggregate market value of $89,950.00.

What past three-month CRWV stock sales are listed in the filing?

The filing lists multiple common stock sales between 12/01/2025 and 02/02/2026. These include transactions labeled as 10b5-1 Sales for Brannin McBee, several McBee-related trusts and LLCs, and a Non-Affiliate Donee, each with specific dates, share amounts, and gross proceeds.

How does the filing reference Rule 10b5-1 trading plans?

Many sale entries are described as “10b5-1 Sales,” and the remarks section refers to adopting a written trading plan or giving trading instructions to satisfy Rule 10b5-1 under the Exchange Act, linking those plans to representations about knowledge of material adverse information.